SCHEMBL30107882

SCHEMBL30107882

Cc1cc(C)cc(-c2ccc3c(c2)c2ccccc2n3-c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc(-n3c4ccccc4c4cc(-c5cc(C)cc(C)c5)ccc43)c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 4/20 0.39
NPY5R Q15761 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
ATM Q13315 2/20 0.37
KDM4E B2RXH2 1/20 0.37
TSPO P30536 1/20 0.36
MAPT P10636 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
ABCG2 Q9UNQ0 2/20 0.35
ABCB1 P08183 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
RAC2 P15153 1/20 0.34
RAC3 P60763 1/20 0.34
CDC42 P60953 1/20 0.34
RAC1 P63000 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24125467 0.96 PTGER4 (0.38) PTGER4NPY5RL3MBTL1ATMKDM4E
SCHEMBL30107781 0.96 L3MBTL1 (0.39) PTGER4L3MBTL1ATMKDM4EMAPT
SCHEMBL30107745 0.93 NR1I3 (0.41) PTGER4NPY5RL3MBTL1ATMKDM4E
SCHEMBL16726754 0.93 L3MBTL1 (0.44) PTGER4NPY5RL3MBTL1ATMKDM4E
SCHEMBL24125475 0.93 L3MBTL1 (0.38) PTGER4L3MBTL1ATMKDM4EMAPT
SCHEMBL30107741 0.92 MEN1 (0.42) PTGER4NPY5RL3MBTL1ATMKDM4E
SCHEMBL24125474 0.92 NR1I3 (0.41) PTGER4NPY5RL3MBTL1ATMKDM4E
SCHEMBL21196575 0.91 CYP1A1 (0.40) PTGER4NPY5RL3MBTL1ATMKDM4E
SCHEMBL30107868 0.90 ATM (0.43) PTGER4NPY5RL3MBTL1ATMKDM4E
SCHEMBL30107836 0.90 ATM (0.43) PTGER4NPY5RL3MBTL1ATMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542260-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11542260-B2 Composition of matter for use in organic light-emitting diodes CRY2, NDUFV3, SLCO1B3 PTGER4 1857/4885NPY5R 3241/4885L3MBTL1 1078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.